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Hyponatraemia is a common electro-lyte abnormality, but distinguishing its underlying cause(s) is usually challenging, 
and extensive laboratory investigations are commonly 
applied.1‒6 Excluding hypothyroidism in patients 
with unexplained hyponatraemia has been widely 
attempted, but the strength of such a link has not 
been clearly defined and is, at times, downplayed.7–9 
Although 10% of patients with hypothyroidism 
also have hyponatraemia, clinicians often ignore 
its clinical significance.1 When hyponatraemia and 
hypothyroidism are found to coexist, the former is 
not necessarily a consequence of the latter, and other 
causes of low sodium (Na) concentrations should still 
be investigated.7,8,10 In a patient with a marked decline 
of Na levels and an undetermined thyroid status, 
clinicians must consider an evaluation of thyroid 
function in the patient’s work-up.10 The implication 
of changes in natraemia status in hypothyroidism has 
yet to be fully elucidated. In spite of this, an absolute 
link between hypothyroidism and Na levels is included 
in standard internal medicine and subspecialty 
textbooks. However, such an association should be 
reaffirmed through individual testing.11–14
Cost-Effective Medicine: 
Recent medical practice
A recent review suggested that about half of the most 
common clinical scenarios in daily practice include 
unnecessary testing and diagnostic approaches.15 
This review documented 146 contemporary medical 
practices that have subsequently been reconsidered 
over the past 10 years. Investigators assessed 1,344 
original articles that studied a novel medical practice 
or tested a conventional one. Only 27% of the articles 
verified an established and tested practice. Of the 
articles that tested current medical practice, 40.2% 
of these practices were found to be ineffective. An 
additional 38% endorsed the importance of an existing 
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abstract: Hyponatraemia is a common electrolyte disturbance, with moderate (serum sodium: 125–129 
mmol/L) to severe (serum sodium: ≤125 mmol/L) forms of the disease occurring in 4–15% of hospitalised patients. 
While it is relatively common, determining the underlying cause of this condition can be challenging and may 
require extensive laboratory investigations. To this end, it is important to ascertain the efficacy of laboratory tests 
in determining the cause of hyponatraemia. Up to 10% of patients with hypothyroidism also have hyponatraemia. 
Routine evaluation of thyroid function is often advocated in cases of low serum sodium. A review and discussion 
of the available literature is presented here to examine this recommendation. 
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امللخ�ص: نق�ض �سوديوم الدم هو ا�سطراب اأيوين �سائع حلاالت مر�سية ترتاوح بني املعتدلة )ال�سوديوم يف الدم: 129-125≥ مليمول/
لرت( اإىل احلادة )ال�سوديوم يف الدم: 125≥ مليمول/لرت( حتدث يف %15-4 من املر�سى املنومني يف ال�ست�سفيات. مع اأنه �سائع ن�سبيا، 
فاإن حتديد �سبب هذا االعتالل ي�سكل حتديا ورمبا يحتاج لفحو�ض خمربية وا�سعة النطاق. حتقيقا لهذه الغاية، فاإن من املهم التاأكد غالبا 
من فعالية الفحو�سات املعملية يف حتديد �سبب نق�ض �سوديوم الدم. اإن ما ي�سل اإىل %10 من املر�سى الذين يعانون من ق�سور الغدة 
الدم  الدرقية يف حاالت انخفا�ض ال�سوديوم يف  الغدة  الروتيني لوظيفة  التقييم  الدم. ولذلك فاإن  اأي�سا نق�ض �سوديوم  الدرقية لديهم 
مطلوب. هنا نقدم عر�سا ومناق�سة لالأدبيات املتوفرة لدرا�سة هذه التو�سية.
مفتاح الكلمات: ال�سببية؛ اأمرا�ض الكلى؛ ق�سور الغدة الدرقية؛ نق�ض �سوديوم الدم.
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practice while 21.8% were unconvincing.15,16 In fact, 
some of the most commonly utilised tests did show 
some beneficial evidence in previously published 
reports.17 However, a careful analysis of the gathered 
data and its clinical significance from the Cochrane 
Database in 2004 and 2011 showed insufficient 
evidence for the necessity of these practices, revealing 
that they were adding more of a load to already 
overburdened healthcare systems.17
Non-Thyroidal I l lness 
Syndrome
Some acute and chronic medical conditions are 
associated with a common biochemical derangement 
of thyroid function, known as non-thyroidal illness 
syndrome (NTIS). This condition is a common cause of 
medical costs in the absence of a causal intrinsic thyroid 
sickness.18 Studies assessing morbidity and mortality 
rates in NTIS subjects treated with thyroid hormones 
revealed no statistically significant findings.18,19 These 
studies found there was no need for specific therapeutic 
interventions, such as the administration of thyroid 
hormones, in patients with various forms of NTIS 
in the context of concurrent systemic illness.18,19 This 
explains, in part, the futility of routine thyroid testing 
in hyponatraemic patients in whom thyroid aberrancy 
can be misleading. Routine testing of the thyroid in 
hyponatraemic patients is based upon little evidence 
and results in unnecessary testing and follow-ups for 
sick euthyroid patients.18,19
the role of vasopressin
The most noticeable peculiarity in clinically significant 
hyponatraemia is its pathogenesis, which remains 
highly debatable. In general, hypothyroidism has been 
associated with increased total body Na, proposing 
the vital role of water retention.6 Regardless of the Na 
levels in hypothyroid states, diminished and/or delayed 
free water load excretion and impaired renal dilution 
capacity are paramount, pointing towards a possible 
role for vasopressin or antidiuretic hormone (ADH) 
and the need for effective water excretion. However, 
such a correlation in patients with hypothyroidism is 
weak. In hypothyroidism, hyponatraemia seems to be 
associated only with the severest cases of myxoedema 
where impaired cardiac function causes baroreceptor-
mediated vasopressin secretion and total body water 
retention.20 In fact, the impaired excretion of water load 
in hypothyroidism has been demonstrated in several 
studies and it has been suggested that inappropriate 
secretion of ADH might mediate water retention.13,20 
Elevated vasopressin levels in patients with 
hypothyroidism have been described in a variety 
of reports, yet the findings were inconsistent.12,21–23 
Previous studies have demonstrated that in rats 
with hypothyroidism, there is no upregulation of 
hypothalamic vasopressin gene expression; therefore 
the reduction in cardiac output and glomerular 
filtration rate (GFR) observed in severe hypothyroi-
dism may be due to non-osmotic stimuli to vasopressin 
release.21,22 In 20 patients with myxoedema, raised 
plasma vasopressin concentrations were observed in 
cases of mild hyponatraemia (Na levels of 130–142 
mmol/L).23 Surprisingly, after a water challenge, 75% 
of the studied individuals did not show a complete 
decline in elevated vasopressin concentrations and 
only 10% had a suppressible vasopressin response. 
This signifies the coexistence of an intrinsic renal 
mechanism unrelated to the vasopressin itself.12,23 
After the achievement of euthyroidism, evaluations 
of urinary excretion and vasopressin inhibition were 
satisfactory following the oral water load.23 
The expected osmotic trigger in patients with 
hypothyroidism seems to be normal. A study by 
Iwasaki et al. assessed eight patients with uncontrolled 
myxoedema due to primary hypothyroidism after 
infusing them with 5% hypertonic saline.21 After 
the saline infusion, severe primary hypothyroidism 
was observed in all patients without a convincing 
suppression of the measured high vasopressin 
levels.12,21 Despite the findings of additional osmotic 
triggering mechanisms, rising plasma osmolality and 
a consequent rise in measured vasopressin levels 
was sufficient in the entire patient group and mild 
hyponatraemia was observed in only two patients.21 
Plasma vasopressin was appropriately suppressed in 
each case during water loading.21 These outcomes 
show that an inappropriate rise in plasma vasopressin 
is not common in myxoedema and that compromised 
water elimination is predominantly due to vasopressin-
independent mechanisms. This results in impaired 
water excretion and urine concentrations even when 





Reduced effective renal plasma flow and diminished 
proximal tubule Na reabsorption have also been 
implicated in the pathophysiology of hypothy-
roidism.22,25,26 In severe cases, the effective arterial 
blood volume can decrease sufficiently to stimulate 
arginine vasopressin (AVP) secretion via baroreceptor 
mechanisms. Additionally, the impaired cardiac 
function that often occurs with advanced myxoedema 
can lead to an elevation in plasma AVP levels. In 
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severe cases, hyponatraemia can occur secondary 
to thyroxine (T)3 deficiency, affecting renal Na 
tubular reabsorption.1,10,12,27 Different factors influence 
Na handling and T3 levels in adult populations, 
including diet, alcohol consumption, hypertension 
and renal status.12 Hyponatraemia and hypothyroidism 
have been found to coincide in a small number of 
selected populations.7,14
role of cellular low sodium/
potassium pump expression and 
interstitial deposition
The Na/potassium (K) adenosine triphosphatase 
(ATPase) enzyme exchange process is the metabolic 
pacemaker of thyroid hormone-responsive tissues, 
leading to an increase in Na pump activity.28 
Either directly at the messenger ribonucleic acid 
transcriptional level or through intermediate cellular 
and ionic regulators, thyroid hormones play an 
essential role in regulating the complex homeostatic 
regulation of ATPase activity in the cell. Na/K/ATPase 
activity is higher in euthyroid states.12,28 Reduced Na/K/
ATPase enzymatic activity and impaired Na/hydrogen 
exchange activity of the proximal tubular borders and 
other specific segments, as part of a decline in cell 
metabolism in hypothyroid conditions, can contribute 
to the diminished proximal tubular capacity for Na 
reabsorption in hypothyroidism.12,22
Another probable influence contributing to 
hyponatraemia in hypothyroidism is the accumulation 
of interstitial mucopolysaccharides resulting in mutual 
solute and fluid retention, diminishing effective tissue 
perfusion and local lymphatic drainage, particularly 
in myxoedema.20 In hypothyroidism, hyponatraemia 
seems to be associated only with the severest cases 
of myxoedema as impaired cardiac function causes 
baroreceptor-mediated vasopressin secretion and 
total body water retention.20 Furthermore, total body 
sodium is increased, evident from isotopic studies, 
and it is likely that the excess Na is bound to the 
mucinous material present in the connective tissue.29 
In addition, the impaired excretion of water load has 
been demonstrated in several studies and it has been 
suggested that inappropriate secretion of ADH might 
mediate water retention.13,20 
role of hypothyroidism type in 
adults
Apart from myxoedema or complete hypopituitarism, 
primary hypothyroidism as the principal cause of 
hyponatraemia in either hospitalised or ambulatory 
patients remains questionable.13,30 Reports from 
studies conducted on congenital hypothyroidism and 
adults with primary hypothyroidism did not show a 
definitive connection between hyponatraemia and 
hypothyroidism, even with a concomitant decline 
in the GFR among hypothyroid patients.31,32 Serum 
creatinine levels could be elevated in patients with 
uncomplicated hypothyroidism without a significant 
decrease in serum Na levels.32 
Despite previous reports describing hypothyroi-
dism as a secondary cause of hyponatraemia, the 
evidence for such an association is poor.1 This 
was shown in recent studies of either congenital 
hypothyroidism, iatrogenic ablated cases or adults 
with primary hypothyroidism; all of these attempted 
to eliminate the influence of comorbid conditions by 
addressing a correlation between thyroid-stimulating 
hormone (TSH) and Na levels and demonstrate a 
significant change in Na concentrations as a result of 
normalising the hypothyroid state.14 Such associations 
were inconclusive due to the small study populations 
and the presence of other confounders, together with 
differences in Na handling mechanisms.1,14 Moreover, 
when hyponatraemia accompanies hypopituitarism, 
secondary hypothyroidism is generally a sign of secondary 
glucocorticoid insufficiency rather than hypothyroi-
dism itself.12
congenital hypothyroidism
When hyponatraemia is detected in congenital 
hypothyroid cases, a lack of thyroid hormones is not the 
chief influencing factor.13,14,20,28–36 In a study conducted 
by Asami et al., no cases of hyponatraemia were found 
in 32 congenital hypothyroid neonates where serum 
Na concentrations did not statistically differ from 
those of 16 control neonates (median sodium level: 
139 mmol/L).31 Furthermore, no association was found 
between the measured thyroid functions and serum 
Na. Moreover, two months after thyroid hormone 
replacement, serum Na levels in the infants had not 
changed significantly.31 In this study, the elimination of 
previously postulated factors that can affect Na handling 
in paediatric populations, such as malnutrition, acute 
gastroenteritis, renal tubular disorders and syndrome 
of inappropriate ADH secretion, did not confirm the 
claimed direct hyponatraemia-hypothyroidism link.31 
This finding suggests other possible causes should 
be investigated.31,37,38 
Further Data and Related 
Mechanisms from Inpatient 
and Outpatient Settings
Studies involving larger numbers of patients found 
that serum Na values were comparable in subjects 
with raised TSH values.10,14 However, laboratory data 
included hospitalised patients with raised TSH values 
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due to non-thyroidal illnesses such as acute hepatitis, 
nephrotic syndrome and depression.10,14 Again, the 
data showed an absence of a clinically applicable 
relationship between newly diagnosed hypothyroidism 
and hyponatraemia.10,14 Moreover, looking exclusively 
at serum samples of newly diagnosed hypothy-
roid patients in ambulatory settings showed a 
statistically significant relationship between lower Na 
concentration in a small number of individuals and 
hypothyroidism; however, the relationship showed no 
clinically significant importance.33 It has been found 
that hyponatraemia was more common in patients 
with impaired renal function at diagnosis (serum 
creatinine concentrations of >1.1 mg/dL) than in 
those with normal renal function, which is another 
condition that can contribute to the progression of 
hyponatraemia in hypothyroid cases.32
A study involving 33,912 patients in a large urban 
general hospital showed matched serum Na levels in 
euthyroid patients and hypothyroid patients (TSH 
>40 U/L; n = 445; Na = 138.6 mmol/L). There was no 
significant difference between the euthyroid subjects 
(11.4%) and the hypothyroid subjects (12.8%) with 
regards to the proportion of patients with serum Na 
lying below the reference interval of 135 mmol/L.14
A small retrospective case series studied 10 
otherwise healthy ambulatory patients with primary 
hypothyroidism. These patients had a median TSH level 
of 193 µU/mL (range: 104.2–515.6 µU/mL; normal range: 
0.40–5.50 µU/mL) and a median Na level of 138 mmol/L 
(range: 136–142 mmol/L; normal range: 135–146 
mmol/L).11 The lowest Na level was 136 mmol/L with a 
concurrent TSH level of 469.7 µU/ml. No single patient 
was found to have a Na level lower than 135 mmol/L.11 
This observation suggests that hypothyroidism alone is 
less likely to contribute to hyponatraemia.
A study conducted in an outpatient setting among 
individuals with hypothyroidism found that for every 
increase of 10 mU/L of TSH, there was a fall of only 
0.14 mmol/L in the subjects’ Na concentrations.33 
Thus, the elevation of TSH required for a clinically 
substantial fall in Na to occur was considerable. 
Again, none of the hypothyroid subjects and only 
two of the control patients had Na values of <120 
mmol/L. However, a relationship between lower Na 
concentrations and hypothyroid status was statistically 
significant, yet unlikely to be of clinical significance.33
Another retrospective study included 128 thyroid-
ablated patients with differentiated thyroid cancers 
who were not receiving thyroid hormone replacement. 
A mean TSH level of 130.3 mU/L and a serum Na level 
of 139.3 mmol/L was observed in hypothyroid cases. 
Findings confirmed the infrequency of hyponatraemia 
in uncontrolled hypothyroidism; despite the observed 
elevated serum creatinine levels, there was no significant 
biochemically detected hyponatraemia.32
In a retrospective review of emergency room 
records including more than 9,000 patients, 
hyponatraemia was significantly more common 
in patients with high TSH levels than the normal 
TSH control group (<15% versus 9%, respectively; 
P <0.01).10 Although serum Na did not show a 
significant correlation with TSH and free T4 levels, 
a significant correlation was seen between free T3 
levels and serum Na levels. Even though such a 
borderline correlation did exist, no proven practical 
electrolyte disturbances were confirmed.10 While there 
may appear to be an association between thyroid 
function and electrolyte disorders, it is most likely 
that clinically-related electrolyte derangements, such 
as hyponatraemia, are only established in extreme 
hypothyroid states.
Most patients with hyponatraemia have one evident 
cause, but there may be other contributory factors. 
Real volume reduction can be initiated by the loss of 
Na and water, leading to decreased tissue perfusion 
and provoking ADH secretion. This response is 
facilitated by carotid sinus-related baroreceptors.20 As 
a consequence, water retention and hyponatraemia can 
develop with the depletion of effective arterial blood 
volume. Because hypothyroidism and hyponatraemia 
are common findings in hospitalised patients, their co-
occurrence may not necessarily be causal; therefore, 
other justifications for hyponatraemia should be 
pursued unless hypothyroidism is severe.8,10,13 A 
patient may not have any symptoms that indicate a 
thyroid illness that warrants further thyroid testing. 
However, an unexplained reduction in the plasma Na 
concentration might inspire physicians to carry out 
further thyroid testing.
Recommendations
Overall, there is no strong evidence that supports 
routine thyroid testing for hyponatraemia in either 
hospital or outpatient encounters as compared to the 
general population. A history of concurrent illness 
and a medications list, as well as a careful physical 
examination, may provide clues to the pathogenesis 
of hyponatraemia. Hyponatraemia in hypothyroidism 
cannot be ignored, but the clinical relevance of this 
association is questionable. TSH levels should be 
determined in challenging cases of hyponatraemia 
where both vasopressin-mediated and intra-renal 
mechanisms may be involved in the pathogenesis of 
the condition. Thyroid assays should be ordered only 
when severe hypothyroidism is suspected in order to 
avoid unnecessary testing.
Ahmed S. Abuzaid and Nathan Birch
Sounding Board | e211
Conclusion
Thyroid function tests are a simple and rapid way 
of obtaining a satisfactory diagnosis for suspected 
hypothyroidism. When a patient presents with 
typical symptoms, the diagnosis usually does not 
require a complex or invasive clinical investigation. 
Although included in many diagnostic algorithms, 
hypothyroidism very rarely causes hyponatraemia. 
Hyponatraemia is not a disease in and of itself, but a 
spectrum of diseases and/or adverse medication effects, 
making it a worthy clinical challenge. Hypothyroidism 
is a possible aetiology, yet other probable causes of 
hyponatraemia should be sought first. The authors 
of this report conclude that there is no compelling 
evidence that suggests the need for routine thyroid testing 
in hyponatraemia. A thorough physical examination 
together with a history of the patient’s concurrent 
illnesses and their current medications should assist 
in identifying the cause of hyponatraemia. The 
current era of medicine demands the elimination of 
unnecessary testing. Therefore, to avoid unessential 
assessments, thyroid testing should only be performed 
in particularly challenging cases of hyponatraemia or 
in possible cases of profound hypothyroidism.
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